To our knowledge, this is the first study examining the connection between the CD34+ cell count and the markers of PAD severity and risk factors for atherosclerosis (diabetes mellitus, smoking, dyslipidaemia) in patients with advanced PAD. The gene discussed is CD34; the disease is peripheral arterial disease.